Sanjeet S Dadwal

Learn More
Over the past 20 years, the number of invasive fungal infections has continued to persist, due primarily to the increased numbers of patients subjected to severe immunosuppression. Despite the development of more active, less toxic antifungal agents and the standard use of antifungal prophylaxis, invasive fungal infections (especially invasive mold(More)
We report a series of breast cancer patients with invasive skin and nail infections with Staphylococcus species that we attribute to the addition of pertuzumab to trastuzumab-based therapy. With the suspicion of an increased incidence of cutaneous infection in patients treated with pertuzumab and trastuzumab-based chemotherapy, treating medical oncologists(More)
A compromised immune system places individuals at a significantly higher risk for many infectious processes. Immunosuppression also increases the risk of malignancy due to the body's decreased ability to perform its normal immunosurveilance and response. It is therefore imperative to have regular thorough evaluations of these patients, as slight(More)
I recently read with great interest the review article " Epidemiology and treatment approaches in management of invasive fungal infections " by Kriengkauykiat et al 1 that was published in your journal. This review drew attention to the steadily growing number of invasive fungal infections (IFIs) that are due to the increasing number of severely(More)
  • 1